Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 166 | 180 | 236 | 1,645 |
| Gross Profit | N/A | 166 | 180 | 236 | 1,645 |
| Operating Expenses | 46,481 | 41,950 | 47,230 | 40,591 | 39,368 |
| Operating Income | -46,481 | -41,784 | -47,050 | -40,355 | -37,723 |
| Interest Expense | 1,810 | 1,790 | 0 | 0 | 0 |
| Other Income | -1,242 | 888 | -1,042 | 979 | -1,807 |
| Pre-tax Income | -49,533 | -42,686 | -48,092 | -39,376 | -39,530 |
| Income Tax | -7,474 | -5,624 | -6,426 | -5,385 | -6,357 |
| Net Income Continuous | -42,059 | -37,062 | -41,666 | -33,991 | -33,173 |
| Net Income | $-42,059 | $-37,062 | $-41,666 | $-33,991 | $-33,173 |
| EPS Basic Total Ops | -0.46 | -0.41 | -0.50 | -0.47 | -0.47 |
| EPS Basic Continuous Ops | -0.46 | -0.41 | -0.50 | -0.47 | -0.47 |
| EPS Diluted Total Ops | -0.46 | -0.41 | -0.50 | -0.47 | -0.47 |
| EPS Diluted Continuous Ops | -0.46 | -0.41 | -0.50 | -0.47 | -0.47 |
| EBITDA(a) | $-44,562 | $-39,717 | $-44,946 | $-37,907 | $-35,479 |